Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.59
HUM's Cash to Debt is ranked higher than
64% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.53 vs. HUM: 0.59 )
HUM' s 10-Year Cash to Debt Range
Min: 0.26   Max: No Debt
Current: 0.59

Equity to Asset 0.42
HUM's Equity to Asset is ranked higher than
80% of the 45 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.38 vs. HUM: 0.42 )
HUM' s 10-Year Equity to Asset Range
Min: 0.25   Max: 0.55
Current: 0.42

0.25
0.55
Interest Coverage 13.72
HUM's Interest Coverage is ranked higher than
77% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.20 vs. HUM: 13.72 )
HUM' s 10-Year Interest Coverage Range
Min: 4.98   Max: 20.5
Current: 13.72

4.98
20.5
F-Score: 5
Z-Score: 3.75
WACC vs ROIC
9.66%
29.63%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 3.96
HUM's Operating margin (%) is ranked higher than
80% of the 45 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.47 vs. HUM: 3.96 )
HUM' s 10-Year Operating margin (%) Range
Min: -3.64   Max: 6.07
Current: 3.96

-3.64
6.07
Net-margin (%) 2.10
HUM's Net-margin (%) is ranked higher than
80% of the 45 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.36 vs. HUM: 2.10 )
HUM' s 10-Year Net-margin (%) Range
Min: -3.74   Max: 4.04
Current: 2.1

-3.74
4.04
ROE (%) 9.96
HUM's ROE (%) is ranked higher than
84% of the 44 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.62 vs. HUM: 9.96 )
HUM' s 10-Year ROE (%) Range
Min: -25.87   Max: 23.54
Current: 9.96

-25.87
23.54
ROA (%) 4.35
HUM's ROA (%) is ranked higher than
87% of the 45 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.79 vs. HUM: 4.35 )
HUM' s 10-Year ROA (%) Range
Min: -7.32   Max: 8.39
Current: 4.35

-7.32
8.39
ROC (Joel Greenblatt) (%) 146.02
HUM's ROC (Joel Greenblatt) (%) is ranked higher than
80% of the 44 Companies
in the Global Health Care Plans industry.

( Industry Median: 166.44 vs. HUM: 146.02 )
HUM' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -87.3   Max: 258.83
Current: 146.02

-87.3
258.83
Revenue Growth (3Y)(%) 9.50
HUM's Revenue Growth (3Y)(%) is ranked higher than
68% of the 41 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.20 vs. HUM: 9.50 )
HUM' s 10-Year Revenue Growth (3Y)(%) Range
Min: 1.1   Max: 27.3
Current: 9.5

1.1
27.3
EBITDA Growth (3Y)(%) 7.80
HUM's EBITDA Growth (3Y)(%) is ranked higher than
66% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. HUM: 7.80 )
HUM' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -9.5   Max: 38.5
Current: 7.8

-9.5
38.5
EPS Growth (3Y)(%) 6.10
HUM's EPS Growth (3Y)(%) is ranked higher than
65% of the 37 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.00 vs. HUM: 6.10 )
HUM' s 10-Year EPS Growth (3Y)(%) Range
Min: -19.9   Max: 41.9
Current: 6.1

-19.9
41.9
» HUM's 10-Y Financials

Financials


Revenue & Net Income
Equity & Asset
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

HUM Guru Trades in Q1 2014

Jim Simons 146,900 sh (New)
Mario Gabelli 5,000 sh (New)
Jeremy Grantham 904,557 sh (+425.04%)
Joel Greenblatt 7,801 sh (+212.41%)
Larry Robbins 5,132,182 sh (+53.64%)
HOTCHKIS & WILEY 3,416,112 sh (+21.15%)
Paul Tudor Jones 5,000 sh (+16.28%)
David Dreman 2,190 sh (+4.53%)
John Hussman 100,000 sh (unchged)
Lee Ainslie Sold Out
Andreas Halvorsen Sold Out
Pioneer Investments 700,981 sh (-5.78%)
Vanguard Health Care Fund 6,226,994 sh (-6.24%)
Steven Cohen 24,443 sh (-11.39%)
» More
Q2 2014

HUM Guru Trades in Q2 2014

Lee Ainslie 771,168 sh (New)
Stanley Druckenmiller 83,900 sh (New)
Paul Tudor Jones 8,191 sh (+63.82%)
Pioneer Investments 824,411 sh (+17.61%)
David Dreman 2,544 sh (+16.16%)
Jeremy Grantham 1,024,957 sh (+13.31%)
Mario Gabelli 5,000 sh (unchged)
Jim Simons Sold Out
HOTCHKIS & WILEY 3,391,273 sh (-0.73%)
Larry Robbins 5,016,176 sh (-2.26%)
Vanguard Health Care Fund 5,698,794 sh (-8.48%)
Joel Greenblatt 5,647 sh (-27.61%)
John Hussman 50,000 sh (-50%)
» More
Q3 2014

HUM Guru Trades in Q3 2014

Andreas Halvorsen 493,602 sh (New)
Ray Dalio 9,311 sh (New)
Steve Mandel 2,174,122 sh (New)
Paul Tudor Jones 15,970 sh (+94.97%)
Jeremy Grantham 1,125,953 sh (+9.85%)
Joel Greenblatt 5,973 sh (+5.77%)
Larry Robbins 5,016,536 sh (+0.01%)
Pioneer Investments 752,240 sh (unchged)
Mario Gabelli 5,000 sh (unchged)
John Hussman 50,000 sh (unchged)
Stanley Druckenmiller Sold Out
Lee Ainslie Sold Out
David Dreman Sold Out
Vanguard Health Care Fund 5,247,894 sh (-7.91%)
HOTCHKIS & WILEY 3,079,572 sh (-9.19%)
» More
Q4 2014

HUM Guru Trades in Q4 2014

Jean-Marie Eveillard 453,653 sh (New)
Steven Cohen 51,500 sh (New)
Louis Moore Bacon 50,000 sh (New)
Andreas Halvorsen 658,313 sh (+33.37%)
Joel Greenblatt 6,252 sh (+4.67%)
Vanguard Health Care Fund 5,247,894 sh (unchged)
Mario Gabelli 5,000 sh (unchged)
Jeremy Grantham 1,106,954 sh (-1.69%)
Ray Dalio 9,011 sh (-3.22%)
Steve Mandel 1,911,536 sh (-12.08%)
Pioneer Investments 599,900 sh (-20.25%)
HOTCHKIS & WILEY 2,366,024 sh (-23.17%)
John Hussman 25,000 sh (-50%)
Larry Robbins 2,207,844 sh (-55.99%)
Paul Tudor Jones 4,900 sh (-69.32%)
» More
» Details

Insider Trades

Latest Guru Trades with HUM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
HOTCHKIS & WILEY 2014-12-31 Reduce -23.17%0.35%$124.17 - $149.07 $ 160.2217%2366024
John Hussman 2014-12-31 Reduce -50%0.28%$124.17 - $149.07 $ 160.2217%25000
Jean-Marie Eveillard 2014-12-31 New Buy0.16%$124.17 - $149.07 $ 160.2217%453653
Steve Mandel 2014-12-31 Reduce -12.08%0.13%$124.17 - $149.07 $ 160.2217%1911536
Andreas Halvorsen 2014-12-31 Add 33.37%0.11%$124.17 - $149.07 $ 160.2217%658313
Lee Ainslie 2014-09-30 Sold Out 1.4%$115.97 - $135.51 $ 160.2226%0
Steve Mandel 2014-09-30 New Buy1.1%$115.97 - $135.51 $ 160.2226%2174122
Andreas Halvorsen 2014-09-30 New Buy0.26%$115.97 - $135.51 $ 160.2226%493602
Vanguard Health Care Fund 2014-09-30 Reduce -7.91%0.15%$115.97 - $135.51 $ 160.2226%5247894
HOTCHKIS & WILEY 2014-09-30 Reduce -9.19%0.14%$115.97 - $135.51 $ 160.2226%3079572
David Dreman 2014-09-30 Sold Out 0.03%$115.97 - $135.51 $ 160.2226%0
Ray Dalio 2014-09-30 New Buy0.01%$115.97 - $135.51 $ 160.2226%9311
Lee Ainslie 2014-06-30 New Buy1.4%$104.74 - $128.95 $ 160.2236%771168
John Hussman 2014-06-30 Reduce -50%0.42%$104.74 - $128.95 $ 160.2236%50000
Vanguard Health Care Fund 2014-06-30 Reduce -8.48%0.17%$104.74 - $128.95 $ 160.2236%5698794
Joel Greenblatt 2014-06-30 Reduce -27.61%$104.74 - $128.95 $ 160.2236%5647
Lee Ainslie 2014-03-31 Sold Out 1.1%$95.59 - $118.78 $ 160.2254%0
Andreas Halvorsen 2014-03-31 Sold Out 0.45%$95.59 - $118.78 $ 160.2254%0
HOTCHKIS & WILEY 2014-03-31 Add 21.15%0.24%$95.59 - $118.78 $ 160.2254%3416112
Vanguard Health Care Fund 2014-03-31 Reduce -6.24%0.13%$95.59 - $118.78 $ 160.2254%6226994
Joel Greenblatt 2014-03-31 Add 212.41%0.01%$95.59 - $118.78 $ 160.2254%7801
Mario Gabelli 2014-03-31 New Buy$95.59 - $118.78 $ 160.2254%5000
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 25.90
HUM's P/E(ttm) is ranked higher than
88% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 28.10 vs. HUM: 25.90 )
HUM' s 10-Year P/E(ttm) Range
Min: 4.25   Max: 34.62
Current: 25.9

4.25
34.62
Forward P/E 15.22
HUM's Forward P/E is ranked higher than
88% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.75 vs. HUM: 15.22 )
N/A
PE(NRI) 25.80
HUM's PE(NRI) is ranked higher than
88% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 28.10 vs. HUM: 25.80 )
HUM' s 10-Year PE(NRI) Range
Min: 4.26   Max: 34.62
Current: 25.8

4.26
34.62
P/B 2.44
HUM's P/B is ranked higher than
76% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.95 vs. HUM: 2.44 )
HUM' s 10-Year P/B Range
Min: 0.71   Max: 3.82
Current: 2.44

0.71
3.82
P/S 0.54
HUM's P/S is ranked higher than
80% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.64 vs. HUM: 0.54 )
HUM' s 10-Year P/S Range
Min: 0.11   Max: 0.65
Current: 0.54

0.11
0.65
PFCF 27.20
HUM's PFCF is ranked higher than
66% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.09 vs. HUM: 27.20 )
HUM' s 10-Year PFCF Range
Min: 2.77   Max: 118.69
Current: 27.2

2.77
118.69
POCF 17.76
HUM's POCF is ranked higher than
70% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.89 vs. HUM: 17.76 )
HUM' s 10-Year POCF Range
Min: 2.5   Max: 32.19
Current: 17.76

2.5
32.19
EV-to-EBIT 9.70
HUM's EV-to-EBIT is ranked higher than
92% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.50 vs. HUM: 9.70 )
HUM' s 10-Year EV-to-EBIT Range
Min: -0.7   Max: 15.9
Current: 9.7

-0.7
15.9
PEG 1.93
HUM's PEG is ranked higher than
82% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.87 vs. HUM: 1.93 )
HUM' s 10-Year PEG Range
Min: 0.14   Max: 4.05
Current: 1.93

0.14
4.05
Shiller P/E 20.89
HUM's Shiller P/E is ranked higher than
88% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 38.08 vs. HUM: 20.89 )
HUM' s 10-Year Shiller P/E Range
Min: 6.41   Max: 73.72
Current: 20.89

6.41
73.72
Days Sales Outstanding 7.90
HUM's Days Sales Outstanding is ranked higher than
94% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 29.38 vs. HUM: 7.90 )
HUM' s 10-Year Days Sales Outstanding Range
Min: 6.84   Max: 18.31
Current: 7.9

6.84
18.31

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.69
HUM's Dividend Yield is ranked lower than
71% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.03 vs. HUM: 0.69 )
HUM' s 10-Year Dividend Yield Range
Min: 0.3   Max: 1.61
Current: 0.69

0.3
1.61
Dividend Payout 0.15
HUM's Dividend Payout is ranked higher than
92% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.00 vs. HUM: 0.15 )
HUM' s 10-Year Dividend Payout Range
Min: 0.09   Max: 0.22
Current: 0.15

0.09
0.22
Yield on cost (5-Year) 0.70
HUM's Yield on cost (5-Year) is ranked lower than
79% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.59 vs. HUM: 0.70 )
HUM' s 10-Year Yield on cost (5-Year) Range
Min: 0.3   Max: 1.61
Current: 0.7

0.3
1.61
Share Buyback Rate 2.10
HUM's Share Buyback Rate is ranked higher than
85% of the 39 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.10 vs. HUM: 2.10 )
HUM' s 10-Year Share Buyback Rate Range
Min: 2.1   Max: -1.4
Current: 2.1

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 4.24
HUM's Price/Tangible Book is ranked higher than
88% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.00 vs. HUM: 4.24 )
HUM' s 10-Year Price/Tangible Book Range
Min: 1.35   Max: 12.43
Current: 4.24

1.35
12.43
Price/DCF (Projected) 0.92
HUM's Price/DCF (Projected) is ranked higher than
90% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.22 vs. HUM: 0.92 )
HUM' s 10-Year Price/DCF (Projected) Range
Min: 0.3   Max: 2.18
Current: 0.92

0.3
2.18
Price/Median PS Value 1.46
HUM's Price/Median PS Value is ranked higher than
62% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.24 vs. HUM: 1.46 )
HUM' s 10-Year Price/Median PS Value Range
Min: 0.21   Max: 3.15
Current: 1.46

0.21
3.15
Price/Peter Lynch Fair Value 3.97
HUM's Price/Peter Lynch Fair Value is ranked higher than
82% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.00 vs. HUM: 3.97 )
HUM' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.23   Max: 4.46
Current: 3.97

0.23
4.46
Price/Graham Number 2.19
HUM's Price/Graham Number is ranked higher than
96% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.00 vs. HUM: 2.19 )
HUM' s 10-Year Price/Graham Number Range
Min: 0.65   Max: 7.09
Current: 2.19

0.65
7.09
Earnings Yield (Greenblatt) 10.30
HUM's Earnings Yield (Greenblatt) is ranked higher than
91% of the 44 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.00 vs. HUM: 10.30 )
HUM' s 10-Year Earnings Yield (Greenblatt) Range
Min: 6.3   Max: 3813.4
Current: 10.3

6.3
3813.4
Forward Rate of Return (Yacktman) 12.38
HUM's Forward Rate of Return (Yacktman) is ranked higher than
65% of the 37 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.48 vs. HUM: 12.38 )
HUM' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 2.3   Max: 54
Current: 12.38

2.3
54

Business Description

Industry: Health Care Plans » Health Care Plans
Compare:UNH, ESRX, WLP, AET, CI » details
Traded in other countries:HUM.Germany,
Humana Inc was organized as a Delaware corporation in 1964. The Company is a health care company that offers a insurance products and health and wellness services. Its segments include Retail, Employer Group, and Healthcare Services. These segments are based on a combination of the type of health plan customer and adjacent businesses centered on integrated care delivery for its health plans and other customers. The Retail segment consists of Medicare and commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products, marketed directly to individuals, and includes its contract with Centers for Medicare and Medicaid Services, or CMS, to administer the LI-NET prescription drug plan program, and contracts with various states to provide Medicaid, dual eligible, and Long-Term Support Services benefits, collectively its state-based contracts. The Employer Group segment consists of Medicare and commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and voluntary benefit products, as well as administrative services only products, or ASO, and its health and wellness products primarily marketed to employer groups. The Healthcare Services segment includes services offered to its health plan members as well as to third parties, including pharmacy, provider services, home based services, integrated behavioral health services, and predictive modeling and informatics services. The Other Businesses category consists of its military services, primarily its TRICARE South Region contract, Puerto Rico Medicaid, and closed-block long-term care insurance policies. The Company's competitors vary by local market and include other managed care companies, national insurance companies, and other HMOs and PPOs, including HMOs and PPOs owned by Blue Cross/Blue Shield plans.
» More Articles for HUM

Headlines

Articles On GuruFocus.com
Undervalued Stocks in Steve Mandel's Portfolio Feb 18 2015 
Top 4 Undervalued stocks in Hotchkis & Wiley’s Portfolio Feb 16 2015 
UNH: A Strong Candidate for Income and Capital Appreciation Dec 12 2014 
Facebook Among New Holdings in Steve Mandel's Portfolio Nov 20 2014 
Add Humana for a Healthier Portfolio Oct 10 2014 
These 16 Stocks Hiked Dividends In The Past Week Sep 21 2014 
Despite Regulation, Transparency and Competition, Aetna Looks Competitive in the Industry Aug 29 2014 
Larry Robbins (Glenview) Presentation From Ira Sohn - Three Long Ideas May 13 2014 
Maintain a Healthy Portfolio with Aetna Mar 24 2014 
3 Cheap Health Care Dividend Stocks with Huge Potential to Grow Dividends Oct 02 2013 


More From Other Websites
Key drivers for Humana’s fully insured employer-sponsored plans Mar 04 2015
Humana’s government-sponsored business suffers from flu Mar 04 2015
Ruling could kill Obamacare Mar 04 2015
Humana’s commercial business generates more revenue in 4Q14 Mar 04 2015
How did Humana’s healthcare services business perform in 4Q14? Mar 04 2015
Humana and Integrated Health Network Announce Accountable Care Agreement to Improve Seniors’... Mar 04 2015
Health insurers on the move Mar 04 2015
Fierce challenges in King v. Burwell Mar 04 2015
Humana Inc. to Present at the Barclays Global Healthcare Conference Mar 03 2015
Humana’s valuations exceed Anthem, Aetna, and Cigna in 4Q14 Mar 03 2015
Humana Inc. to Present at the Barclays Global Healthcare Conference Mar 03 2015
UnitedHealth Group: The history of a health insurance giant Mar 03 2015
Humana reacts to a premium stabilization program in 4Q14 Mar 03 2015
Humana’s medical care ratio exceeds Aetna and UnitedHealth Group Mar 03 2015
BioMarin Pharmaceutical Inc. (BMRN) and Other Top New Picks of Healthcare-Focused Visium Asset... Mar 03 2015
Remke Markets to trim fat from workforce through health insurance Mar 02 2015
5 Takeover Targets Hedge Funds Are Betting On Feb 26 2015
7.5M Obamacare Customers Face 255% Premium Increase If SCOTUS Strips Subsidies Feb 26 2015
Zacks Industry Outlook Highlights: UnitedHealth Group, WellCare Health Plans, Centene and Humana -... Feb 26 2015
Zacks Industry Outlook Highlights: UnitedHeath Group, Anthem, Aetna, Humana and Health Net - Press... Feb 26 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK